@misc{indiciaef3a166b0e974,
  title = {Ovarian carcinosarcoma genomics and pre-clinical models highlight the N-MYC pathway as a key driver and susceptibility to EMT-targeting therapy},
  author = {Ho, G. Y. and Kyran, E. and Bedo, J. and Wakefield, M. and Ennis, D. and Mirza, H. and Cooke, S. and Lieschke, E. and Vandenberg, C. and Kondrashova, O. and Upstill-Goddard, R. and Bailey, U.-M. and Biankin, S. and Roxburgh, P. and Glasspool, R. and Bryson, G. and Biankin, A. and Ratnayake, G. and McNally, O. and Traficante, N. and DeFazio, A. and Bowtell, D. and McNeish, I. and Papenfuss, A. and Scott, C. and Barker, H.},
  year = {2020},
  doi = {10.1101/2020.11.24.396796},
  url = {https://www.biorxiv.org/content/10.1101/2020.11.24.396796v1},
  note = {Source identifier: 10.1101/2020.11.24.396796}
}